CORTHealthcareLarge-Cap
CORCEPT THERAPEUTICS INC Insider Trading Activity
Every SEC Form 4 insider transaction reported for CORCEPT THERAPEUTICS INC (CORT), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Are CORT insiders buying or selling?
CORCEPT THERAPEUTICS INC insiders reported 17 open-market buys ($17.2M) and 213 sells ($232.7M) across 230 Form 4 filings — a net selling position of $215.6M.
Source: SEC EDGAR Form 4
Key Statistics (as of Sep 4, 2026)
Total Form 4 filings
230
SEC EDGAR
Insider filers
15
Insider buys (17)
$17.2M
Insider sells (213)
$232.7M
Insider sentiment
Net sellingNet insider flow of $215.6M in net selling.
Recent CORT insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 4, 2026 | Sean Maduck | President, Corcept Endocrinology The power of attorney under which this form was signed is on file w | Sale | 25.0K | $114.43 | $2.9M |
| Sep 4, 2026 | Roberto Wandenkolk Vieira | President, Oncology | Sale | 58.3K | $110.76 | $6.5M |
| Aug 28, 2026 | Kimberly Park | Director | Sale | 26.7K | $122.55 | $3.3M |
| Aug 27, 2026 | Sean Maduck | President, Corcept Endocrinology The power of attorney under which this form was signed is on file w | Sale | 31.0K | $125.58 | $3.9M |
| Aug 20, 2026 | David L Mahoney | Director | Sale | 103.6K | $118.25 | $12.3M |
| Aug 18, 2026 | Sean Maduck | President, Corcept Endocrinology The power of attorney under which this form was signed is on file w | Sale | 3.7K | $114.49 | $419.5K |
| Aug 18, 2026 | James N Wilson | Director | Sale | 10.0K | $111.43 | $1.1M |
| Aug 18, 2026 | Gary Charles Robb | Chief Business Officer | Sale | 10.0K | $116.26 | $1.2M |
| Aug 12, 2026 | Sean Maduck | President, Corcept Endocrinology The power of attorney under which this form was signed is on file w | Sale | 1.0K | $114.52 | $118.1K |
| Aug 12, 2026 | William Guyer | Chief Development Officer | Sale | 16.3K | $113.43 | $1.8M |
| Aug 6, 2026 | William Guyer | Chief Development Officer | Sale | 3.7K | $113.12 | $418.6K |
| Aug 5, 2026 | Sean Maduck | President, Corcept Endocrinology The power of attorney under which this form was signed is on file w | Sale | 20.3K | $114.70 | $2.3M |
| Aug 5, 2026 | Joseph Douglas Lyon | Chief Accounting & Technology Officer | Sale | 1.5K | $114.16 | $175.8K |
| Aug 3, 2026 | Atabak Mokari | Chief Financial Officer | Sale | 80.0K | $114.71 | $9.2M |
| Jul 17, 2026 | James N Wilson | Director | Sale | 10.0K | $88.30 | $883.0K |
| Jul 17, 2026 | Atabak Mokari | Chief Financial Officer | Sale | 40.0K | $87.71 | $3.5M |
| Jul 8, 2026 | William Guyer | Chief Development Officer | Sale | 20.0K | $93.13 | $1.9M |
| Jul 6, 2026 | Sean Maduck | President, Corcept Endocrinology The power of attorney under which this form was signed is on file w | Sale | 25.0K | $88.35 | $2.2M |
| Jun 18, 2026 | James N Wilson | Director | Sale | 10.0K | $83.20 | $832.0K |
| Jun 18, 2026 | David L Mahoney | Director | Sale | 20.0K | $84.53 | $1.7M |
| Jun 17, 2026 | Atabak Mokari | Chief Financial Officer | Sale | 40.0K | $81.15 | $3.2M |
| Jun 4, 2026 | William Guyer | Chief Development Officer | Sale | 20.0K | $70.60 | $1.4M |
| Jun 3, 2026 | Sean Maduck | President, Corcept Endocrinology The power of attorney under which this form was signed is on file w | Sale | 25.0K | $70.21 | $1.8M |
| Jun 3, 2026 | Atabak Mokari | Chief Financial Officer | Sale | 40.0K | $70.00 | $2.8M |
| Jun 2, 2026 | BELANOFF JOSEPH K | Chief Executive Officer | Sale | 12.8K | $69.74 | $895.3K |
Showing the 25 most recent of 230 Form 4 filings for CORCEPT THERAPEUTICS INC.
Most active CORT insiders
- Sean Maduck44 filings
- Joseph Douglas Lyon36 filings
- Daniel N Swisher JR32 filings
- William Guyer32 filings
- Gary Charles Robb24 filings
Ask anything about CORT insider activity
Use Trabud's AI agent to query CORCEPT THERAPEUTICS INC's Form 4 history in plain English — "Show me CORT CEO purchases this year" or compare it against any other ticker.
Open the AI agentCORT insider trading FAQ
Are CORCEPT THERAPEUTICS INC insiders buying or selling?
Across 230 SEC Form 4 filings, CORCEPT THERAPEUTICS INC (CORT) insiders reported 17 open-market purchases totaling $17.2M and 213 sales totaling $232.7M. That is a net selling position of $215.6M.
How many insiders trade CORT stock?
15 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for CORCEPT THERAPEUTICS INC. The most recent filing was accepted on Sep 4, 2026.
Where does Trabud get CORT insider trading data?
All CORT insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.